{"id":810702,"date":"2025-02-10T02:03:25","date_gmt":"2025-02-10T07:03:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/"},"modified":"2025-02-10T02:03:25","modified_gmt":"2025-02-10T07:03:25","slug":"pharming-group-to-participate-in-february-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/","title":{"rendered":"Pharming Group to participate in February investor conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>Leiden, the\u00a0<\/strong><br \/>\n        <strong>Netherlands, February 10, 2025: <\/strong>Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of February:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt;text-align:left\">\n          <strong>Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025<\/strong><br \/>\n          <br \/>Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET\/14:40 CET. A live webcast and replay of the presentation will be available in the \u201cUpcoming Events\u201d and \u201cNews\u201d sections of Pharming\u2019s website.<\/li>\n<\/ul>\n<p align=\"justify\">For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CU6WHzRQbtAudHD4j3jS4ttIyLqCx_i_Dnlo2UORf_AMT2jo8wBILTMDrGPJqzpdaKLBUAZKD-g4KkyhRUR059pmsH6RU4oHy7g_wvYGypk=\" rel=\"nofollow\" target=\"_blank\">investor@pharming.com<\/a> or your Oppenheimer representative.<br \/>\u00a0<\/p>\n<p align=\"justify\">\n        <strong>About Pharming Group N.V.<\/strong><br \/>\n        <br \/>Pharming Group N.V. (EURONEXT Amsterdam: PHARM\/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. <\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jtwT5JfpdxN0QOechkGlPEPhRiF-t2FZWGwvLPXbpuGyXheJRhWKbar_1FVTllyZ7UxFXv4JABzTqOhCOyKzFJwy3KH65fxPzKq8hVFpeMw=\" rel=\"nofollow\" target=\"_blank\">www.pharming.com<\/a> and find us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GEdXCsCdM7H_bgQ5GSS_4lGzR7R2weyPOwEUYNmANDzn7Sbbc3owMofi1lmgRJUM_LUYS9D3IT8jrMMFDLDKI0Gl163K02SpUh65lknj3-4=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further public information, contact:<\/strong><br \/>\n        <br \/>\n        <em>Pharming Group, Leiden, the Netherlands<\/em><br \/>\n        <br \/>Michael Levitan, VP Investor Relations &amp; Corporate Communications<br \/>T: +1 (908) 705 1696<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CU6WHzRQbtAudHD4j3jS4ttIyLqCx_i_Dnlo2UORf_CvV9PRbDSyRllEwgtFdA53r7ObwU-qU7-Y6PWwETDE4gXE0d9ad-mHYYA8Tv2SRtw=\" rel=\"nofollow\" target=\"_blank\">investor@pharming.com<\/a><\/p>\n<p align=\"left\">\n        <em>FTI Consulting, London, United Kingdom<\/em><br \/>\n        <br \/>Victoria Foster Mitchell\/Alex Shaw\/Amy Byrne<br \/>T: +44 203 727 1000<\/p>\n<p align=\"left\">\n        <em>LifeSpring Life Sciences Communication, Amsterdam, the Netherlands<\/em><br \/>\n        <br \/>Leon Melens<br \/>T: +31 6 53 81 64 27<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1qifktdW1oP0wSYE0jKw8Il6tFjiWF7NhWnHZBN8RaqkRKRwDy745JC5UthjG3wYj78_kVHUKjYZ6-4_vQ65ntdDpw3ZDT3c9GjXCmlnANI=\" rel=\"nofollow\" target=\"_blank\">pharming@lifespring.nl<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/4d8b675d-d239-4363-8a46-297e5d124f98\">Pharming attending Investor Conferences February 2025_EN_10FEB25<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YmFhOWFkMzMtNDY0Yi00YjI3LWJiNmYtZTZlOWJmOGExZWNmLTEwMTI1NDk=\/tiny\/Pharming-Group-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Leiden, the\u00a0 Netherlands, February 10, 2025: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of February: Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025 Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET\/14:40 CET. A live webcast and replay of the presentation will be available in the \u201cUpcoming Events\u201d and \u201cNews\u201d sections of Pharming\u2019s website. For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at investor@pharming.com or your Oppenheimer representative.\u00a0 About Pharming Group N.V. Pharming Group N.V. (EURONEXT &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pharming Group to participate in February investor conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810702","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharming Group to participate in February investor conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharming Group to participate in February investor conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Leiden, the\u00a0 Netherlands, February 10, 2025: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of February: Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025 Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET\/14:40 CET. A live webcast and replay of the presentation will be available in the \u201cUpcoming Events\u201d and \u201cNews\u201d sections of Pharming\u2019s website. For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at investor@pharming.com or your Oppenheimer representative.\u00a0 About Pharming Group N.V. Pharming Group N.V. (EURONEXT &hellip; Continue reading &quot;Pharming Group to participate in February investor conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-10T07:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pharming Group to participate in February investor conference\",\"datePublished\":\"2025-02-10T07:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/\",\"name\":\"Pharming Group to participate in February investor conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==\",\"datePublished\":\"2025-02-10T07:03:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-february-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharming Group to participate in February investor conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharming Group to participate in February investor conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Pharming Group to participate in February investor conference - Market Newsdesk","og_description":"Leiden, the\u00a0 Netherlands, February 10, 2025: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of February: Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025 Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET\/14:40 CET. A live webcast and replay of the presentation will be available in the \u201cUpcoming Events\u201d and \u201cNews\u201d sections of Pharming\u2019s website. For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at investor@pharming.com or your Oppenheimer representative.\u00a0 About Pharming Group N.V. Pharming Group N.V. (EURONEXT &hellip; Continue reading \"Pharming Group to participate in February investor conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-10T07:03:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pharming Group to participate in February investor conference","datePublished":"2025-02-10T07:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/","name":"Pharming Group to participate in February investor conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==","datePublished":"2025-02-10T07:03:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0NzUwOCM0MDIwNTc3OTAjMjAwMDk3Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-february-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pharming Group to participate in February investor conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810702"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810702\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}